Pasithea Therapeutics Corp. (KTTAW) Interest & Investment Income (2023 - 2026)

Pasithea Therapeutics has disclosed Interest & Investment Income across 4 years of filings, most recently posting $410416.0 for Q2 2026.

• In Q2 2026, Interest & Investment Income rose 654.11% year-over-year to $410416.0; the TTM figure through Jun 2026 stood at $1.1 million (up 322.3% YoY), while the FY2025 annual figure was $327193.0, down 22.68% from the prior year.
• Interest & Investment Income came in at $410416.0 for Q2 2026 at Pasithea Therapeutics, down from $450338.0 in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $450338.0 in Q1 2026 to a low of $43396.0 in Q3 2025.
• Average Interest & Investment Income over 4 years is $159641.3, with a median of $123073.5 recorded in 2023.
• Year-over-year, Interest & Investment Income sank 69.16% in 2025 and surged 853.2% in 2026.
• Over 4 years, Interest & Investment Income stood at $172825.0 in 2023, then slumped by 53.43% to $80483.0 in 2024, then surged by 126.29% to $182128.0 in 2025, then jumped by 125.34% to $410416.0 in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $410416.0 in Q2 2026, $450338.0 in Q1 2026, and $182128.0 in Q4 2025.